Arab Journal of Gastroenterology
Volume 12, Issue 3 , Pages 119-124 , September 2011

Predictors of hepatocyte proliferative activity in chronic hepatitis B and C vs. steatohepatitis as assessed by the monoclonal antibody MIB1-Ki-67

  • Mahmoud El-Bendary

      Affiliations

    • Tropical Medicine Unit, Mansoura University Hospital, Mansoura Faculty of Medicine, Mansoura University, Mansoura, Egypt
    • Corresponding Author InformationCorresponding author. Address: Tropical Medicine, Tropical Medicine Unit, Mansoura University Hospital, Mansoura Faculty of Medicine, Mansoura University, Mansoura 3516, Egypt. Tel.: +20 102592205; fax: +20 502267563.
    • ,
  • Hatem Elalfy

      Affiliations

    • Tropical Medicine Unit, Mansoura University Hospital, Mansoura Faculty of Medicine, Mansoura University, Mansoura, Egypt
    • ,
  • Khaled Zalata

      Affiliations

    • Pathology Department, Mansoura Faculty of Medicine, Mansoura University, Mansoura, Egypt

Received 10 December 2010 ,Accepted 28 July 2011.

References 

  1. El Zanaty F, Way A. Egypt demographic and health survey 2008. Cairo, Egypt: Ministry of Health; 2009;[March]
  2. Irving WL, Salmon D, Boucher C, et al. Acute hepatitis C virus infection. Eurosurveillance. 2008;13(21):
  3. Fattovich G, Stroffolini T, Zagni I, et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127(Suppl):S35–S50
  4. El Serag HB. Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology. 2004;127(5 Suppl. 1):S27–S34
  5. Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology. 2002;122(6):1609–1619
  6. Capocaccia R, Sant M, Berrino F, et al. Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Am J Gastroenterol. 2007;102(8):1661–1670[quiz 1660, 1671]
  7. Hussein M, Ibrahim A, Abdella H, et al. Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients. Indian J Cancer. 2008;45(4):167–172
  8. Anzola M. Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. J Viral Hepat. 2004;11(5):383–393
  9. Kao CF, Chen SY, Chen JY, et al. Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein. Oncogene. 2004;23(14):2472–2483
  10. Sato Y, Kato J, Takimoto R, et al. Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB. Gut. 2006;55(12):1801–1808
  11. Cardin R, D’Errico A, Fiorentino M, et al. Hepatocyte proliferation and apoptosis in relation to oxidative damage in alcohol-related liver disease. Alcohol Alcohol. 2002;37(1):43–48
  12. Koskinas J, Petraki K, Kavantzas N, et al. Hepatic expression of the proliferative marker ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma. J Viral Hepat. 2005;12(6):635–641
  13. Wong N, Lai P, Lee SW, et al. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size and cirrhosis. Am J Pathol. 1999;154(1):37–43
  14. Dutta U, Kench J, Byth K, et al. Hepatocellular proliferation and development of hepatocellular carcinoma: a case-control study in chronic hepatitis C. Hum Pathol. 1998;29(11):1279–1284
  15. Farinati F, Cardin R, D’Errico A, et al. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron and lipid peroxidation. Hepatology. 1996;23(6):1468–1475
  16. Rodríguez Díaz JL, Rosas Camargo V, Vega Vega O, et al. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study. Clin Oncol. 2007;19(3):197–203
  17. Scholzen T, Gerdes J. The ki-67 protein: From the known and the unknown. J Cell Physiol. 2000;182(3):311–322
  18. Hernandez Rodriguez NA, Correa E, Sotelo R, et al. Ki-67: a proliferative marker that may predict pulmonary metastases and mortality of primary osteosarcoma. Cancer Detect Prev. 2001;25(2):210–215
  19. Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol. 2002;8(3):385–392
  20. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group. Hepatology. 1996;24(2):289–293
  21. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22(6):696–699
  22. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94(9):2467–2474
  23. Chisari FV. Hepatitis B virus transgenic mice: insights into the virus and the disease. Hepatology. 1995;22(4 Pt 1):1316–1325
  24. Raptis I, Koskinas J, Emmanouil T, et al. Changing relative roles of hepatitis B and C viruses in the aetiology of hepatocellular carcinoma in Greece. Epidemiological and clinical observations. J Viral Hepat. 2003;10(6):450–454
  25. Koike K. Transgenic mouse models of viral hepatitis: insight into viral hepatocarcinogenesis. Viral Hepat Rev. 1999;5(4):177–203
  26. Farinati F, Cardin R, Fiorentino M, et al. Imbalance between cytoproliferation and apoptosis in hepatitis C virus related chronic liver disease. J Viral Hepat. 2001;8(1):34–40
  27. Nakamura T, Hayama M, Sakai T, et al. Proliferative activity of hepatocytes in chronic viral hepatitis as revealed by immunohistochemistry for proliferating cell nuclear antigen. Hum Pathol. 1993;24(7):750–753
  28. De Lima VMR, Oliveira CPMS, Alves VAF, et al. A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma. J Hepatol. 2008;49(6):1055–1061
  29. Kasprzak A, Adamek A, Biczysko W, et al. Intracellular expression of the proliferative marker ki-67 and viral proteins (NS3, NS5A and C) in chronic, long lasting Hepatitis C Virus (HCV) infection. Folia Histochem Cytobiol. 2007;45(4):357–366
  30. Wilfredo Canchis P, Gonzalez SA, Isabel Fiel M, et al. Hepatocyte proliferation in chronic hepatitis C: correlation with degree of liver disease and serum alpha-fetoprotein. Liver Int. 2004;24(3):198–203
  31. Matsumoto K, Tanimoto K, Michitaka K, et al. [Detection of ki-67 in liver biopsy specimens using monoclonal antibody to Mib-1]. Rinsho Byori. 1999;47(10):956–960
  32. Cuadrado A, Orive A, Garcia Suarez C, et al. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma. Obes Surg. 2005;15(3):442–446
  33. Sepulveda Flores RN, Vera Cabrera L, Flores Gutierrez JP, et al. Obesity-related non-alcoholic steatohepatitis and TGF-beta1 serum levels in relation to morbid obesity. Ann Hepatol. 2002;1(1):36–39
  34. Hasegawa T, Yoneda M, Nakamura K, et al. Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther. 2001;15(10):1667–1672
  35. Mohamed WS, Omar MM, Khayri TM, et al. Assessment of the proliferative marker ki-67 and p53 protein expression in HBV- and HCV-related hepatocellular carcinoma cases in Egypt. Int J Health Sci (Qassim). 2008;2(1):27–34
  36. Mitselou A, Karapiperides D, Nesseris I, et al. Altered expression of cell cycle and apoptotic proteins in human liver pathologies. Anticancer Res. 2010;30(11):4493–4501

PII: S1687-1979(11)00081-5

doi: 10.1016/j.ajg.2011.07.008

Arab Journal of Gastroenterology
Volume 12, Issue 3 , Pages 119-124 , September 2011

Article Tools

* Image Usage & Resolution